Is Taysha Gene Therapies, Inc. (TSHA) a Buy, Sell, or Hold?
NASDAQ : TSHA
Taysha Gene Therapies, Inc. — Stock Grades
$5.8538 USD
-$0.01 (-0.11%)
- Volume
- 994.32K
- Average Volume
- 3.05M
- Market Capitalization
- $1.87B
- P/E Ratio
- -15.29
- Dividend Yield
- 0.00%
- Price Target
- $14.00
- Year High
- $7.30
- Year Low
- $2.54
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $14.04
TSHA Stock Grades
| Date | Grading Company | Previous Grade | New Grade | Action |
|---|---|---|---|---|
| 2026-07-21 | Goldman Sachs | Buy | Buy | Maintain |
| 2026-07-02 | Citizens | Market Outperform | Market Outperform | Maintain |
| 2026-06-30 | Needham | Buy | Buy | Maintain |
| 2026-06-30 | Baird | Outperform | Outperform | Maintain |
| 2026-06-23 | BMO Capital | Outperform | Outperform | Maintain |
| 2026-06-23 | B of A Securities | Buy | Buy | Maintain |
| 2026-06-23 | Citizens | Market Outperform | Market Outperform | Maintain |
| 2026-06-22 | Needham | Buy | Buy | Maintain |
| 2026-04-06 | Canaccord Genuity | Buy | Buy | Maintain |
| 2026-03-19 | Needham | Buy | Buy | Maintain |
| 2026-03-19 | Chardan Capital | Buy | Buy | Maintain |
| 2026-03-03 | Needham | Buy | Buy | Maintain |
| 2026-01-06 | Chardan Capital | Buy | Buy | Maintain |
| 2026-01-05 | Wells Fargo | Overweight | Overweight | Maintain |